The Sarcoma Biology and Outcome Project
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Malignant Mesenchymoma
- Sarcoma
- Sarcoma of Bone and Connective Tissue
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
SarcBOP is initiated at the National Center for Tumor Diseases (NCT) Heidelberg. The infrastructure is designed universally to enable extension to further centers. All patients with newly diagnosed or preexistent STBS at participating centers are intended to be registered within SarcBOP. Prior to in...
SarcBOP is initiated at the National Center for Tumor Diseases (NCT) Heidelberg. The infrastructure is designed universally to enable extension to further centers. All patients with newly diagnosed or preexistent STBS at participating centers are intended to be registered within SarcBOP. Prior to inclusion, patients have to give their written informed consent. The following data will be collected and stored: Demographics Comorbidities Clinical characteristics at diagnosis, relapse and progression Treatments including DRG and OPS data Longitudinal disease assessments Clinical outcome Genomic, transcriptomic, epigenomic and proteomic data Quality-of-life assessments Furthermore, biological samples will be collected and processed by the Sample Processing Laboratory of the Heidelberg Center for Personalized Oncology and the NCT Biobank.
Tracking Information
- NCT #
- NCT04758325
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Richard F. Schlenk, Prof.Dr.med National Center for Tumour Disease Study Director: Christoph E. Heilig, Dr. med. National Center for Tumour Disease Study Director: Stefan Fröhling, Prof. Dr. National Center for Tumour Disease
Get Well Soon